1-4 of 4
Miranda Lim, BSN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with Untreated Acute Myeloid Leukemia (AML)

Maro N. Ohanian, DO, Tara L Lin, MD, Ellen K. Ritchie, MD, Michael Craig, MD, Apurv Agrawal, MD, Kathleen G. Halka, MD, Vinit Karur, MD, Naveen Pemmaraju, MD, Gautam Borthakur, MD, Sarah Aminov, Miranda Lim, BSN, Sherry A. Pierce, BSN, BA, Natalie Sacarakis, Stacy Minor, Ana Tari Ashizawa, PhD, William Hahne, MD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD, Gail J. Roboz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1387.
https://doi.org/10.1182/blood-2018-99-113693
Published: 2018
Journal Articles

An Open-Label, Phase I Study of Dasatinib in Combination with Decitabine in Patients (Pts) with Accelerated or Blastic Phase Chronic Myeloid Leukemia (CML)

Yasmin Abaza, MD, Hagop M. Kantarjian, MD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, Naval Daver, MD, Farhad Ravandi, MD, Srdan Verstovsek, MD PhD, Jan A. Burger, MD PhD, Zeev Estrov, MD, Maro Ohanian, DO, Miranda Lim, BSN, Rita Assi, MD, Elias J. Jabbour, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2016) 128 (22): 5433.
https://doi.org/10.1182/blood.V128.22.5433.5433
Published: 2016
Journal Articles

Safety, Pharmacokinetics, and Efficacy of BP-100-1.01 (Liposomal Grb-2 Antisense Oligonucleotide) in Patients with Refractory or Relapsed Acute Myeloid Leukemia (AML), Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Myelodysplastic Syndrome (MDS)

Maro Ohanian, DO, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, Michael Andreeff, MD PhD, Elias Jabbour, Marina Konopleva, MD PhD, Miranda Lim, BSN, Sherry Pierce, BSN, BA, Susan O'Brien, MD, Bradley G. Somer, MD, Ana Tari, PhD, William Wierda, MD PhD, Srdan Verstovsek, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2015) 126 (23): 3801.
https://doi.org/10.1182/blood.V126.23.3801.3801
Published: 2015
Journal Articles

Frequency and Impact of Molecular Response’s with Nilotinib (Tasigna) in Patients (Pts) with Newly Diagnosed Philadelphia Chromosome (Ph)-Positive Chronic Myelogenous Leukemia in Early Chronic Phase (CML-CP)

Naval Daver, Hagop M. Kantarjian, MD, Susan O'Brien, MD, Elias Jabbour, MD, Sherry Pierce, BSN, BA, Miranda Lim, BSN, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Marina Konopleva, MD PhD, Courtney D. DiNardo, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2014) 124 (21): 3156.
https://doi.org/10.1182/blood.V124.21.3156.3156
Published: 2014